{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:34:12Z","timestamp":1791477252596,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.eururo.2016.03.052","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T17:39:48Z","timestamp":1462037988000},"page":"522-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned"],"prefix":"10.1016","volume":"70","author":[{"given":"Lorenz","family":"Leitner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmistha","family":"Guggenb\u00fchl-Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie C.","family":"Kn\u00fcpfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jure","family":"Tornic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Sammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Mehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2016.03.052_bib0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000353274","article-title":"Systematic review of the epidemiology of urinary incontinence and detrusor overactivity among patients with neurogenic overactive bladder","volume":"41","author":"Ruffion","year":"2013","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.eururo.2016.03.052_bib0175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.eururo.2015.07.071","article-title":"Summary of European Association of Urology (EAU) guidelines on neuro-urology","volume":"69","author":"Groen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0180","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","article-title":"Lower urinary tract dysfunction in the neurological patient: clinical assessment and management","volume":"14","author":"Panicker","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.eururo.2016.03.052_bib0190","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ucl.2010.07.002","article-title":"Urologic complications of the neurogenic bladder","volume":"37","author":"Gormley","year":"2010","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.eururo.2016.03.052_bib0195","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000054774","article-title":"Renal failure in patients with neurogenic lower urinary tract dysfunction","volume":"20","author":"Lawrenson","year":"2001","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.eururo.2016.03.052_bib0200","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.eururo.2012.08.060","article-title":"Efficacy and adverse events of antimuscarinics for treating overactive bladder: network meta-analyses","volume":"62","author":"Buser","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0205","doi-asserted-by":"crossref","first-page":"e16718","DOI":"10.1371\/journal.pone.0016718","article-title":"Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach","volume":"6","author":"Kessler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.eururo.2016.03.052_bib0210","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2012.02.036","article-title":"Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis","volume":"62","author":"Madhuvrata","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0215","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.eururo.2013.10.033","article-title":"An updated systematic review and statistical comparison of standardised mean outcomes for the use of botulinum toxin in the management of lower urinary tract disorders","volume":"65","author":"Mangera","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0220","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1464-410X.2011.10675.x","article-title":"Botulinum toxin injections into the detrusor","volume":"108","author":"W\u00f6llner","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.03.052_bib0225","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM200003023420918","article-title":"Treatment of neurogenic incontinence with botulinum toxin A","volume":"342","author":"Schurch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2016.03.052_bib0230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0235","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.eururo.2008.08.048","article-title":"Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results","volume":"55","author":"Giannantoni","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2016.03.052_bib0245","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","article-title":"Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies","volume":"21","author":"Schafer","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2016.03.052_bib0250","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/nau.22546","article-title":"International Continence Society guidelines on urodynamic equipment performance","volume":"33","author":"Gammie","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2016.03.052_bib0255","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/mus.10231","article-title":"Extensor digitorum brevis test and resistance to botulinum toxin type A","volume":"26","author":"Gordon","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.eururo.2016.03.052_bib0260","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.eururo.2011.07.002","article-title":"Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Cruz","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0265","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/j.juro.2012.01.125","article-title":"Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivity","volume":"187","author":"Ginsberg","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0270","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1212\/WNL.0b013e3182a2ca4d","article-title":"OnabotulinumtoxinA improves quality of life in patients with neurogenic detrusor overactivity","volume":"81","author":"Chancellor","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.eururo.2016.03.052_bib0275","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2007.10.013","article-title":"Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity\/neurogenic overactive bladder: a systematic literature review","volume":"53","author":"Karsenty","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0280","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000251175","article-title":"Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years","volume":"83","author":"Stoehrer","year":"2009","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2016.03.052_bib0285","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.urology.2012.11.010","article-title":"Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis","volume":"81","author":"Kennelly","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2016.03.052_bib0290","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.eururo.2011.12.011","article-title":"Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates","volume":"61","author":"Dowson","year":"2012","journal-title":"Eur Urol"},{"issue":"Suppl 6","key":"10.1016\/j.eururo.2016.03.052_bib0295","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bju.13085","article-title":"Neurogenic lower urinary tract dysfunction (NLUTD) in patients with spinal cord injury: long-term urodynamic findings","volume":"115","author":"Sch\u00f6ps","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2016.03.052_bib0300","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.eururo.2010.09.024","article-title":"Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis","volume":"58","author":"Kessler","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0305","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.eururo.2015.07.001","article-title":"Tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review","volume":"68","author":"Schneider","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0310","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.eururo.2016.01.010","article-title":"Transcutaneous electrical nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review","volume":"69","author":"Gross","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000052421","article-title":"Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen","volume":"39","author":"Costa","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2016.03.052_bib0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/fampra\/19.4.333","article-title":"Meeting patient expectations of care: the major determinant of satisfaction with out-of-hours primary medical care?","volume":"19","author":"McKinley","year":"2002","journal-title":"Fam Pract"},{"key":"10.1016\/j.eururo.2016.03.052_bib0325","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/intqhc\/mzh006","article-title":"Meeting patient's expectations in primary care consultations in Lithuania","volume":"16","author":"Zebiene","year":"2004","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.eururo.2016.03.052_bib0330","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJM199609193351213","article-title":"Part 1: quality of care--what is it?","volume":"335","author":"Blumenthal","year":"1996","journal-title":"N Engl J Med"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816300306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283816300306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T12:27:33Z","timestamp":1536755253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283816300306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0302283816300306"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2016.03.052","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726307589.793522334","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More Than 15 Years of Experience with Intradetrusor OnabotulinumtoxinA Injections for Treating Refractory Neurogenic Detrusor Overactivity: Lessons to Be Learned","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2016.03.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}